Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients

Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients

<p>Abstract</p> <p>Background</p> <p>Gastric cancer relapse occurs in about 30% of the patients treated with gastrectomy and D2-lymphadenectomy, mainly as distant or peritoneal metastases. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been associated with an imp...

Full description

Bibliographic Details
Main Authors: Costa Wilson L, Coimbra Felipe J F, Ribeiro Héber S C, Diniz Alessandro L, de Godoy André, Begnami MariaDirleiFS, Silva Milton J B, Fanelli Marcelo F, Mello Celso A L
Format: Article
Language:English
Published: BMC 2012-09-01
Series:World Journal of Surgical Oncology
Subjects:
Gastric cancer
HIPEC
Perioperative chemotherapy
Online Access:http://www.wjso.com/content/10/1/195

Internet

http://www.wjso.com/content/10/1/195

Similar Items